Innovation Medical(002173)
Search documents
脑机接口概念上扬,创新医疗涨停,翔宇医疗等大涨
Zheng Quan Shi Bao Wang· 2025-08-05 06:32
机构表示,脑机接口已历经五十年发展历程,多国为期十年的前期投入已助力脑机接口技术和产业从应 用萌芽期迈入普及期,有望在十年内实现"应用解决方案效果良好,多类解决方案走向成熟的目标"。脑 机接口是事关经济社会发展的战略性领域,其深化发展有利于我国在未来产业科技竞争中抢占制高点。 消息面上,此前有报道称,苹果公司正在与脑机接口公司合作开发"使用大脑信号操纵苹果设备"的技术 标准。周一公布的一段展示视频,首次演示了这项技术的进展。视频显示,作为这场未知试验的参与 者,患有渐冻症的马克.杰克逊在2023年成为首批植入Stentrode的患者。他现在仅凭意念,就能在iPad的 屏幕上选择目标,打开应用程序并撰写信息。 脑机接口概念5日盘中发力上扬,截至发稿,翔宇医疗涨超16%,创新医疗(002173)涨停,爱朋医疗 (300753)涨超8%,倍益康等涨超5%。 ...
人脑工程概念午后异动 创新医疗涨停
Zheng Quan Shi Bao Wang· 2025-08-05 06:12
Group 1 - The brain engineering concept experienced significant market activity, with several companies in the sector seeing notable stock price increases [1] - Innovation Medical (002173) reached the daily limit increase, indicating strong investor interest [1] - Xiangyu Medical saw a rise of over 15%, reflecting positive market sentiment towards the brain engineering sector [1] Group 2 - Other companies such as Aipeng Medical (300753), Sanbo Brain Science (301293), and Entropy Technology (301330) also experienced slight increases in their stock prices, contributing to the overall positive trend in the industry [1]
创新医疗股价下跌1.14% 脑机接口技术应用受关注
Sou Hu Cai Jing· 2025-08-04 14:46
Group 1 - The core stock price of Innovation Medical on August 4 was 14.75 yuan, down 0.17 yuan or 1.14% from the previous trading day [1] - The trading volume on that day was 566,532 hands, with a transaction amount of 815 million yuan [1] - Innovation Medical operates in the healthcare service sector, focusing on medical health industry investment and medical services, providing comprehensive medical services through its medical institutions [1] Group 2 - The Zhejiang University Brain-Machine Intelligence National Key Laboratory recently launched a new generation of neuromorphic brain-like computer "Wukong," with neuron scale approaching that of a macaque brain [1] - The National Medical Insurance Administration has established a billing project for brain-machine interface medical services in March this year, with the global brain-machine interface medical application market expected to reach 40 billion USD by 2030 [1] - Innovation Medical is regarded as a related concept stock and has attracted market attention due to developments in the brain-machine interface sector [1] Group 3 - On August 4, the net outflow of main funds for Innovation Medical was 58.69 million yuan, accounting for 0.96% of the circulating market value [1] - Over the past five days, the cumulative net outflow of main funds reached 183.42 million yuan, representing 2.99% of the circulating market value [1]
8月4日中银创新医疗混合C净值下跌0.72%,近1个月累计上涨10.05%
Sou Hu Cai Jing· 2025-08-04 13:41
Group 1 - The core point of the news is the performance of the Zhongyin Innovation Medical Mixed C Fund, which has shown significant returns over various time frames, with a year-to-date return of 80.47% and a recent one-month return of 10.05% [1] - As of June 30, 2025, the fund's total assets amounted to 2.686 billion yuan, indicating a substantial scale for a fund established in October 2020 [1] - The top ten stock holdings of the fund account for a combined 62.83%, with notable investments in companies such as Innovent Biologics (8.33%) and Hengrui Medicine (8.08%) [1] Group 2 - The fund manager, Zheng Ning, has a strong background in the investment industry, having previously held senior positions at Taikang Asset Management and Zhonggeng Fund Management [2] - Zheng Ning has been managing the Zhongyin Innovation Medical Mixed Fund since July 1, 2022, and has also taken on managerial roles for other funds within the Zhongyin family [2]
医疗服务板块8月4日跌0.26%,昭衍新药领跌,主力资金净流出9.69亿元
Sou Hu Cai Jing· 2025-08-04 08:32
证券之星消息,8月4日医疗服务板块较上一交易日下跌0.26%,昭衍新药领跌。当日上证指数报收于 3583.31,上涨0.66%。深证成指报收于11041.56,上涨0.46%。医疗服务板块个股涨跌见下表: | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | | 成交额(元) | | --- | --- | --- | --- | --- | --- | --- | | 688265 | 南模生物 | 43.73 | 20.01% | | 4.08万 | 1.66亿 | | 688621 | 阳光诺和 | 66.54 | 14.84% | | 12.60万 | 8.15亿 | | 301201 | 诚达药业 | 28.10 | 4.04% | | 10.58万 | 2.93亿 | | 688222 | 成都先导 | 24.74 | 3.82% | | 33.55万 | 7.91亿 | | 002172 | 澳洋健康 | 4.25 | 3.41% | | 70.07万 | 2.93亿 | | 688046 | 药康生物 | 16.41 | 3.01% | | 4.55万 | 7293.23万 | | ...
医疗服务板块8月1日跌1.44%,睿智医药领跌,主力资金净流出19.46亿元
Zheng Xing Xing Ye Ri Bao· 2025-08-01 08:42
| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 300149 | 睿智医药 | 13.30 | -6.60% | 97.13万 | 13.47 乙 | | 688710 | 益诺思 | 42.93 | -4.34% | 2.77万 | 1.21亿 | | 300725 | 药石科技 | 47.25 | -4.08% | 22.57万 | 10.92亿 | | 603456 | 九州药业 | 18.32 | -3.48% | 63.91万 | 11.90亿 | | 603259 | 药明康德 | 93.00 | -3.40% | 89.33万 | 83.98亿 | | 300759 | 康龙化成 | 30.10 | -3.22% | 61.22万 | 18.70亿 | | 688202 | 美迪西 | 61.60 | -2.84% | 7.28万 | 4.55 Z | | 002173 | 创新医疗 | 14.92 | -2.74% | 81.94万 | 12.53亿 | | 002821 | 司 ...
这一领域迎利好,主力资金抢筹股出炉
Zheng Quan Shi Bao Wang· 2025-08-01 01:03
(原标题:突然大爆发,601606股价创新高!这一领域迎利好,主力资金抢筹股出炉) 我国脑机接口正处于由基础研究向临床应用转化的重要阶段。 7月31日,市场全天震荡调整,三大股指午后均跌超1%。算力概念股活跃,英维克、川润股份等多股涨 停。创新药概念延续强势,钢铁、煤炭等周期股集体调整,油气、有色金属等板块跌幅居前。 军工股尾盘爆发,长城军工(601606)涨停再创新高,北方长龙涨17.22%,捷强装备、内蒙一机等个股尾 盘快速上涨。 国家医保局支持脑机接口等新技术进入临床并收费 据央视新闻报道,为支持药品和医疗器械创新发展,国家医保局制定新上市药品首发价格机制,新增了 100多项与医疗新技术相关的价格项目。国家医保局从立项、定价等方面入手,畅通新技术的收费通 道,助力满足临床急需的新技术新产品加快收益回报。 | | | 主力资金净流入额居前的脑机接口概念股一览 | | | | --- | --- | --- | --- | --- | | 代码 | 简称 | 总市值 (亿元) | 年内涨跌幅 (%) | 7月31日丰力 净流入额 | | 300418 | 昆仑万维 | 450.67 | -6.70 | (亿 ...
突然!多只A股尾盘暴拉!发生了什么?
券商中国· 2025-07-31 12:14
尾盘,再现异动! 7月31日,A股三大指数集体调整,截至今日收盘,沪指下跌1.18%,深证成指跌1.73%,创业板指跌1.66%。从盘面上看,钢铁、煤 炭、有色等前期过热的板块集体大跌,AI、创新药概念股则逆市上涨。 值得关注的是,临近收盘时,创新医疗、爱朋医疗、三博脑科等多只脑机接口概念股直线拉升,创新医疗一度逼近涨停。从消息面来 看,当天下午,脑机接口板块迎来一则利好消息。据报道,国家医保局支持脑机接口等新技术进入临床并收费。 脑机接口概念股尾盘拉升 7月31日,临近A股尾盘时分,多只脑机接口概念股突然直线拉升,创新医疗涨幅一度达到9.62%,爱朋医疗一度涨超9%,三博脑科、 倍益康、熵基科技、南京熊猫等相关概念股均有拉升动作。 | 壳价 叠加 重播 统计 | | 分时 1分钟 5分钟 15分钟 30分钟 60分钟 日线 更多 > | | 画线 F10 | 标记 -自选 返回 | | 创新医疗 002173 | | | | 医疗保健 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 创新医疗 分时 ...
创新医疗:聘任杨建荣为公司财务总监
Mei Ri Jing Ji Xin Wen· 2025-07-31 11:37
延伸阅读: 2024年1至12月份,创新医疗的营业收入构成为:医疗服务业务占比99.52%,其他业务占比0.48%。 截至发稿,创新医疗市值为63亿元。 每经AI快讯,创新医疗(SZ 002173)7月30日晚间发布公告称,经马建建总裁提名,公司董事会同意聘 任杨建荣为公司财务总监。 ST宁科:聘任金相宇为公司财务总监 宝馨科技徐业香辞去公司董事、财务总监职务 延江股份:聘任刘培源为公司财务总监 ...
医疗服务板块7月31日跌1.21%,昭衍新药领跌,主力资金净流出11.26亿元
Zheng Xing Xing Ye Ri Bao· 2025-07-31 08:37
| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 300683 | 海特生物 | 56.33 | 8.37% | 17.94万 | | 10.12亿 | | 002173 | 创新医疗 | 15.34 | 7.72% | 76.57万 | | 11.37亿 | | 301096 | 百诚医药 | 58.45 | 7.09% | 17.58万 | | 10.01亿 | | 000710 | 贝瑞基因 | 14.64 | 4.95% | 56.75万 | | 8.30亿 | | 301293 | 三博脑科 | 50.08 | 3.58% | 14.57万 | | 7.19 Z | | 300149 | 睿智医药 | 14.24 | 3.56% | 134.38万 | | 18.69亿 | | 000504 | *ST生物 | 10.67 | 3.39% | 5.73万 | | 6098.79万 | | 300244 | 迪安诊断 | 16.10 | 1.58% | 37.94万 | | ...